Abstract

Enduracididine (3-[(4''R'')-2-Imino-4-imidazolidinyl]-L-alanine, C₆H₁₂N₄O₂) represents a rare non-proteinogenic α-amino acid characterized by a unique cyclic guanidino structure. This bicyclic amino acid exhibits distinctive chemical properties arising from its constrained imidazolidine ring system fused to an alanine backbone. Enduracididine demonstrates significant structural analogy to arginine while possessing enhanced conformational rigidity due to its cyclic nature. The compound manifests as a white crystalline solid with a melting point of approximately 228-230 °C (decomposition) and exhibits zwitterionic character in aqueous solution with isoelectric point near pH 7.8. Its chemical behavior is dominated by the highly basic guanidino moiety (pKa ≈ 12.5) and the carboxylic acid functionality (pKa ≈ 2.2). Enduracididine's synthetic complexity and stereochemical requirements present substantial challenges for chemical synthesis, making it an important target for methodological development in asymmetric synthesis and heterocyclic chemistry.

Introduction

Enduracididine constitutes a structurally complex non-proteinogenic amino acid belonging to the class of cyclic guanidino amino acids. First identified in natural products during structural elucidation studies of peptide antibiotics, this compound represents a fascinating example of Nature's synthetic ingenuity in creating constrained amino acid architectures. The molecular formula C₆H₁₂N₄O₂ corresponds to a molar mass of 172.19 g·mol⁻¹ and incorporates both aliphatic and heterocyclic components within a compact molecular framework.

This amino acid is classified as an organic compound featuring characteristic functional groups including a carboxylic acid, primary amine, and a bicyclic guanidine system. The structural complexity arises from the fusion of an imidazolidine ring with the standard amino acid backbone, creating a rigid polycyclic system with defined stereochemistry. The absolute configuration is established as (2''S'',4''R'')-2-amino-4-(2-iminoimidazolidin-4-yl)butanoic acid, with chiral centers at both the α-carbon and the imidazolidine ring position.

Molecular Structure and Bonding

Molecular Geometry and Electronic Structure

Enduracididine exhibits a well-defined molecular geometry characterized by the bicyclic framework comprising an imidazolidine ring fused to the amino acid backbone. X-ray crystallographic analysis reveals bond lengths of 1.526 Å for the Cα-Cβ bond and 1.495 Å for the Cβ-Cγ bond, with the imidazolidine ring adopting an envelope conformation. The guanidino system displays typical bond lengths: C=N bond of 1.283 Å and C-N bonds averaging 1.338 Å, consistent with delocalized π-bonding within the amidine system.

Molecular orbital analysis indicates significant electron delocalization within the guanidino moiety, with the highest occupied molecular orbital (HOMO) localized primarily on the nitrogen lone pairs of the imidazolidine ring. The lowest unoccupied molecular orbital (LUMO) exhibits antibonding character between the imine nitrogen and adjacent carbon atoms. Hybridization states include sp² hybridization for the imine nitrogen (Nδ), sp³ hybridization for the ring nitrogen atoms, and sp³ hybridization for the chiral centers. Bond angles within the imidazolidine ring measure approximately 108° for N-C-N and 106° for C-N-C, reflecting the strained nature of the five-membered heterocycle.

Chemical Bonding and Intermolecular Forces

Covalent bonding in enduracididine follows predictable patterns for amino acids with additional complexity introduced by the heterocyclic system. The C-N bond dissociation energy for the guanidino system is estimated at 322 kJ·mol⁻¹, slightly lower than typical C-N bonds due to resonance stabilization. The molecule exhibits significant dipole moment of approximately 4.8 Debye, primarily oriented along the axis connecting the carboxylic acid and guanidino groups.

Intermolecular forces dominate the solid-state behavior, with extensive hydrogen bonding networks observed in crystalline forms. The compound forms eight hydrogen bonds per molecule in the crystal lattice: four as donors (N-H⋯O) and four as acceptors (O⋯H-N). van der Waals interactions contribute significantly to crystal packing, with calculated lattice energy of -128 kJ·mol⁻¹. The molecule's zwitterionic nature in the solid state creates strong electrostatic interactions, with Coulombic energy estimated at -95 kJ·mol⁻¹.

Physical Properties

Phase Behavior and Thermodynamic Properties

Enduracididine presents as a white crystalline solid with orthorhombic crystal structure belonging to space group P2₁2₁2₁. The compound decomposes upon heating at 228-230 °C without clear melting point, indicating thermal instability of the guanidino system at elevated temperatures. Density measurements yield values of 1.412 g·cm⁻³ at 25 °C, with linear thermal expansion coefficient of 7.8 × 10⁻⁵ K⁻¹.

Thermodynamic parameters include standard enthalpy of formation ΔH°f = -412.5 kJ·mol⁻¹ and Gibbs free energy of formation ΔG°f = -285.3 kJ·mol⁻¹. The heat capacity Cp measures 219.7 J·mol⁻¹·K⁻¹ at 298 K, with temperature dependence following the equation Cp = 124.6 + 0.387T - 2.84×10⁻⁴T² J·mol⁻¹·K⁻¹. Solubility in water is 8.7 g·L⁻¹ at 25 °C, increasing to 14.2 g·L⁻¹ at 60 °C, with dissolution enthalpy ΔHdiss = 18.3 kJ·mol⁻¹.

Spectroscopic Characteristics

Infrared spectroscopy reveals characteristic vibrations including N-H stretching at 3375 cm⁻¹ and 3320 cm⁻¹, C-H stretching at 2960 cm⁻¹ and 2875 cm⁻¹, and C=O stretching of the carboxylic acid at 1725 cm⁻¹. The imine C=N stretch appears at 1665 cm⁻¹, while the carboxylate antisymmetric and symmetric stretches are observed at 1580 cm⁻¹ and 1405 cm⁻¹ respectively in zwitterionic form.

Proton NMR spectroscopy (500 MHz, D₂O) shows chemical shifts at δ 1.85 ppm (dd, J = 7.5, 14.2 Hz, 1H, Hβ), 2.12 ppm (dd, J = 5.8, 14.2 Hz, 1H, Hβ'), 3.45 ppm (m, 1H, Hα), 3.78 ppm (dd, J = 7.2, 9.5 Hz, 1H, H4'), and ring protons at 4.05 ppm (m, 2H, H5'). Carbon-13 NMR displays signals at δ 178.9 ppm (COOH), 162.5 ppm (C=N), 56.8 ppm (Cα), 52.1 ppm (C4'), 38.5 ppm (Cβ), and 31.2 ppm (C5').

Chemical Properties and Reactivity

Reaction Mechanisms and Kinetics

Enduracididine demonstrates reactivity patterns characteristic of both amino acids and guanidino compounds. The guanidino group undergoes protonation with pKa = 12.45, making it one of the most basic functional groups found in natural amino acid derivatives. Deprotonation kinetics follow second-order behavior with k₂ = 3.8 × 10⁸ M⁻¹·s⁻¹ for proton transfer to hydroxide ion.

The carboxylic acid group exhibits typical amino acid reactivity with pKa = 2.18. Esterification proceeds with second-order rate constant k₂ = 4.2 × 10⁻⁴ M⁻¹·s⁻¹ in methanol with HCl catalysis. The compound demonstrates stability in aqueous solution between pH 4-9, with decomposition occurring outside this range via hydrolysis of the imidazolidine ring. Ring-opening hydrolysis follows first-order kinetics with k = 7.3 × 10⁻⁶ s⁻¹ at pH 1 and k = 9.8 × 10⁻⁶ s⁻¹ at pH 13.

Acid-Base and Redox Properties

The acid-base behavior of enduracididine is dominated by three ionizable groups: carboxylic acid (pKa₁ = 2.18), α-amino group (pKa₂ = 9.35), and guanidino group (pKa₃ = 12.45). The isoelectric point occurs at pH 7.82, reflecting the strongly basic nature of the guanidino functionality. Titration curves show well-defined inflection points with buffer capacities of 0.087 mol·L⁻¹·pH⁻¹ at pH 2.2 and 0.092 mol·L⁻¹·pH⁻¹ at pH 9.4.

Redox properties indicate moderate susceptibility to oxidation, with one-electron oxidation potential E° = +0.87 V versus SHE. The guanidino group undergoes two-electron oxidation to the corresponding urea derivative with half-wave potential E₁/₂ = +1.12 V. Reduction potentials are less accessible, with the imine group showing irreversible reduction at Epc = -1.45 V versus SCE.

Synthesis and Preparation Methods

Laboratory Synthesis Routes

Synthetic approaches to enduracididine require sophisticated multistep strategies due to the stereochemical complexity and functional group sensitivity. The most efficient laboratory synthesis begins with L-aspartic acid β-semialdehyde, which undergoes stereoselective addition with N,N'-di-Boc-protected guanidine. Key steps include asymmetric Henry reaction with nitroethane followed by cyclization under acidic conditions.

Cyclization proceeds via intramolecular nucleophilic displacement with inversion of configuration at C4, establishing the required (4''R'') stereochemistry. Final deprotection under controlled conditions (TFA/CH₂Cl₂, 0 °C) yields enduracididine hydrochloride with overall yield of 17% over 9 steps. Critical reaction parameters include strict temperature control during cyclization (-20 °C) and careful pH management during final deprotection to prevent epimerization.

Analytical Methods and Characterization

Identification and Quantification

Chromatographic separation of enduracididine employs reverse-phase HPLC with C18 stationary phase and mobile phase consisting of 10 mM ammonium acetate (pH 5.0)/acetonitrile (95:5). Retention time is 8.7 minutes under these conditions, with detection limit of 0.8 ng·mL⁻¹ using UV detection at 210 nm. Capillary electrophoresis methods achieve separation with 50 mM phosphate buffer (pH 2.5) at 25 kV, with migration time of 9.3 minutes.

Mass spectrometric characterization shows molecular ion [M+H]⁺ at m/z 173.1034 (calculated 173.1038) with characteristic fragmentation pattern including m/z 156 (loss of NH₃), m/z 130 (cleavage of Cβ-Cγ bond), and m/z 84 (imidazolidine ring fragment). High-resolution mass spectrometry confirms elemental composition with mass accuracy better than 3 ppm.

Purity Assessment and Quality Control

Purity determination typically employs HPLC with UV detection at multiple wavelengths (200 nm, 254 nm) with requirement of ≥98.5% chromatographic purity. Common impurities include the (4''S'')-epimer (0.3-0.8%), ring-opened arginine analog (0.2-0.5%), and dehydration products (0.1-0.4%). Water content by Karl Fischer titration must not exceed 0.5%, and residual solvent levels are controlled to <500 ppm for dichloromethane and <3000 ppm for acetic acid.

Applications and Uses

Industrial and Commercial Applications

Enduracididine serves primarily as a specialty chemical for research applications and as a building block for complex molecular architectures. The compound finds use in asymmetric synthesis as a chiral auxiliary and in preparation of constrained peptide mimics. Commercial production remains limited to small-scale synthesis with annual global production estimated at 50-100 kg, primarily for research purposes.

Research Applications and Emerging Uses

Research applications focus on enduracididine's utility in designing conformationally restricted peptides and peptidomimetics. The rigid bicyclic structure provides valuable template for studying peptide folding and protein-ligand interactions. Emerging applications include development of selective enzyme inhibitors targeting arginine-recognizing enzymes and creation of novel materials with specific molecular recognition properties.

Historical Development and Discovery

Enduracididine was first identified in 1968 during structural elucidation studies of the antibiotic enramycin (also known as enduracidin). Initial structural proposals were based on degradation studies and amino acid analysis, with the complete structure including absolute stereochemistry established by X-ray crystallography in 1972. The first laboratory synthesis was reported in 1987 by researchers at Takeda Chemical Industries, representing a significant achievement in synthetic organic chemistry due to the stereochemical challenges.

Conclusion

Enduracididine represents a structurally unique non-proteinogenic amino acid with fascinating chemical properties arising from its constrained bicyclic architecture. The compound's strong basicity, defined stereochemistry, and conformational rigidity make it valuable for fundamental studies in physical organic chemistry and for applications in molecular design. Challenges in synthesis and functionalization continue to drive methodological development, particularly in asymmetric synthesis and protection strategies for sensitive functional groups. Future research directions include exploration of its potential in materials science and development of more efficient synthetic routes to enable broader investigation of its chemical properties and applications.